🇺🇸 AO-128 in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 21 April 2025 – 21 April 2026
- Total reports: 3
Most-reported reactions
- Atrial Fibrillation — 1 report (33.33%)
- Cerebral Infarction — 1 report (33.33%)
- Ventricular Extrasystoles — 1 report (33.33%)
Other Diabetes approved in United States
Frequently asked questions
Is AO-128 approved in United States?
AO-128 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for AO-128 in United States?
Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.